---
title: "300485.SZ (300485.SZ) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/300485.SZ/news.md"
symbol: "300485.SZ"
name: "300485.SZ"
parent: "https://longbridge.com/en/quote/300485.SZ.md"
datetime: "2026-05-21T12:08:24.419Z"
locales:
  - [en](https://longbridge.com/en/quote/300485.SZ/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/300485.SZ/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/300485.SZ/news.md)
---

# 300485.SZ (300485.SZ) — Related News

### [Science Sun Pharm released its first-quarter performance, with a net profit attributable to the parent company of 4.6633 million yuan, a decrease of 88.33%](https://longbridge.com/en/news/284345801.md)
*2026-04-28T09:45:37.000Z*
> Science Sun Pharm released its first-quarter report for 2026, with operating revenue of 90.4389 million yuan, a year-on-

### [Science Sun Pharm: Subsidiary receives approval notice for the listing application of chemical raw materials](https://longbridge.com/en/news/283618876.md)
*2026-04-22T07:51:28.000Z*
> Science Sun Pharm announced that its subsidiary Beijing Sai'er Biological Pharmaceutical Co., Ltd. recently received the

### [Science Sun Pharm: Subsidiary withdraws registration application for Dapagliflozin tablets](https://longbridge.com/en/news/283493332.md)
*2026-04-21T11:49:51.000Z*
> Science Sun Pharm announced that its subsidiary Sai'er Biotechnology has received a notification from the National Medic

### [Science Sun Pharm released its 2025 annual performance, turning a profit of 14.571 million yuan](https://longbridge.com/en/news/280985562.md)
*2026-03-30T09:01:14.000Z*
> Science Sun Pharm released its 2025 annual report, with operating revenue of 405 million yuan, a year-on-year decrease o

### [Science Sun Pharm plans to distribute a cash dividend of RMB 0.3 for every 10 shares to all shareholders in the fiscal year 2025](https://longbridge.com/en/news/280984341.md)
*2026-03-30T08:52:35.000Z*
> Sina Finance reported on March 30th that Science Sun Pharm announced that it plans to distribute a cash dividend of RMB 

### [Science Sun Pharm's subsidiary withdraws a drug registration application](https://longbridge.com/en/news/279907862.md)
*2026-03-20T08:17:05.000Z*
> Science Sun Pharm announced that its subsidiary Beijing Sai'er Biological Pharmaceutical Co., Ltd. has received the "Not

### [Science Sun Pharm: Expected net profit in 2025 is between 13.7737 million yuan and 20 million yuan](https://longbridge.com/en/news/274269128.md)
*2026-01-30T07:58:48.000Z*
> Science Sun Pharm expects a net profit of RMB 13.7737 million to RMB 20 million in 2025, marking the company's turnaroun

### [Science Sun Pharm: Shareholder Ma Li has reduced her holdings by 1.33%](https://longbridge.com/en/news/273081911.md)
*2026-01-20T12:14:47.000Z*
> Science Sun Pharm announced that Ma Li, the concerted actor of the actual controller of the controlling shareholder, has

### [Science Sun Pharm: The drug registration application for Dapagliflozin Metformin Sustained-Release Tablets has been accepted](https://longbridge.com/en/news/268554347.md)
*2025-12-04T08:08:05.000Z*
> Science Sun Pharm announced that its subsidiary Sai'er Biotechnology received the acceptance notice from the National Me

### [Science Sun Pharm: Change of Production Responsible Person for Drug Production License of Subsidiary](https://longbridge.com/en/news/267134057.md)
*2025-11-24T08:38:10.000Z*
> Science Sun Pharm announced that its subsidiary Junyuan Pharmaceutical recently received the "Drug Manufacturing License